LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Novel Chromogenic Screening Medium Developed for MRSA

By LabMedica International staff writers
Posted on 13 Aug 2014
Image: Typical colonies of methicillin-resistant Staphylococcus aureus (MRSA) grew and formed blue-colored colonies on MRSA-chrom media after 24 hours of incubation at 35 °C (Photo courtesy of Kohjin Bio Co., Ltd).
Image: Typical colonies of methicillin-resistant Staphylococcus aureus (MRSA) grew and formed blue-colored colonies on MRSA-chrom media after 24 hours of incubation at 35 °C (Photo courtesy of Kohjin Bio Co., Ltd).
A novel chromogenic screening agar medium for methicillin-resistant Staphylococcus aureus (MRSA) has been developed, as rapid and definite detection of MRSA is important not only diagnosis but also for preventing the spread of this bacteria.

MRSA is known as a major nosocomial pathogen, which causes a variety of clinical symptoms including septicemia, pneumonia, and postsurgical toxic shock syndrome and treatment of infections by MRSA has been problematic since MRSA is resistant to many antimicrobial agents.

Scientists at the Kohjin Bio Co., Ltd. (Saitama, Japan) compared the company’s MRSA-chrom media with other commercially available media to detect MRSA. Forty-two strains of MRSA including 41 clinical isolates from nasal cavity were inoculated into the media for the inclusivity study. For the exclusivity study, 52 gram-positive strains other than MRSA, 36 gram-negative strains, and 3 yeasts were inoculated into suitable culture media.

A total of 42 MRSA strains grew and formed typical blue- and mauve-colored colonies on MRSA-chrom and CHROMagar MRSA (CHROMagar Microbiology; Paris, France) in 24 hours. Of 42 MRSA strains, 37 strains grew and formed typical yellow colonies with egg yolk turbid reaction for S. aureus on three other media in 48 hours. All of the other microbes tested including 17 methicillin-sensitive S. aureus (MSSA) strains failed to grow on MRSA-chrom. The colonies of Bacillus cereus were spread and had a frosted glass appearance and as a result, these colonies could be distinguished from MRSA easily. When the scientists tested the 50 clinical specimens, they found that both chromogenic media detected MRSA as typical colored colony from 33 specimens after 24 hours of incubation.

The authors concluded that the novel chromogenic medium, MRSA-chrom, developed for the screening of MRSA was excellent for both selectivity and detectability. Therefore, they suggested that MRSA-chrom was a useful alternative for rapid and definitely screening of MRSA. Moreover, MRSA-chrom had a good growth for MRSA since it contained no sodium chloride. The study was published in the August 2014 issue of the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

Kohjin Bio Co., Ltd.
CHROMagar Microbiology


Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Automated MALDI-TOF MS System
EXS 3000

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more